MED13L Gene Transposition of the Great Arteries Dextro-looped 1 NGS Genetic DNA Test
Comprehensive Genetic Analysis for Congenital Heart Defects
The MED13L Gene Transposition of the Great Arteries Dextro-looped 1 NGS Genetic DNA Test represents a breakthrough in cardiovascular genetic diagnostics. This advanced testing methodology provides crucial insights into genetic mutations associated with serious congenital heart conditions, enabling early intervention and personalized medical management strategies.
What This Test Measures and Detects
This sophisticated genetic test specifically targets mutations in the MED13L gene using Next Generation Sequencing (NGS) technology. The test identifies:
- Pathogenic variants in the MED13L gene associated with transposition of great arteries
- Genetic markers for dextro-looped cardiac malformations
- Inherited patterns of congenital heart disease susceptibility
- Specific nucleotide changes affecting cardiac development pathways
- Risk assessment for familial transmission of cardiovascular anomalies
Who Should Consider This Genetic Test
This comprehensive genetic analysis is recommended for individuals experiencing:
- Family history of congenital heart defects or transposition of great arteries
- Unexplained cardiac symptoms in infancy or childhood
- Previous diagnosis of congenital heart disease requiring genetic confirmation
- Planning pregnancy with known genetic risk factors
- Multiple family members with cardiovascular anomalies
- Suspected genetic syndromes involving cardiac development
Key Benefits of MED13L Genetic Testing
Undergoing this advanced genetic analysis provides numerous advantages:
- Early detection of genetic predisposition to congenital heart defects
- Personalized treatment planning based on genetic profile
- Informed family planning decisions and genetic counseling
- Proactive monitoring and preventive care strategies
- Reduced uncertainty through definitive genetic diagnosis
- Improved medical management of associated health conditions
Understanding Your Test Results
Our comprehensive genetic counseling services help you interpret your results effectively:
- Positive Result: Indicates presence of MED13L gene mutation associated with increased risk of congenital heart defects
- Negative Result: Suggests absence of tested MED13L mutations, though other genetic factors may still contribute
- Variant of Uncertain Significance: Requires additional family studies and clinical correlation
- All results include detailed genetic counseling to discuss implications and next steps
Test Pricing Information
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art genetic testing facilities ensure consistent, reliable results regardless of your location.
Take Control of Your Cardiovascular Health
Don’t let genetic uncertainty impact your health decisions. Our expert genetic counselors and cardiovascular specialists are ready to provide comprehensive support throughout your testing journey. Early genetic detection can significantly improve outcomes and provide peace of mind for you and your family.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your MED13L genetic testing appointment and take the first step toward understanding your cardiovascular genetic profile.
